XML 51 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 28, 2019
Dec. 29, 2018
Dec. 30, 2017
Cash Flows from Operating Activities:      
Net loss $ (386,618,000) $ (214,295,000) $ (194,506,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation and amortization 119,824,000 100,494,000 65,997,000
Non-cash restructuring and other related 13,937,000 7,291,000 29,237,000
Amortization of debt discount and issuance costs 19,162,000 11,161,000 11,342,000
Interest accretion related to financing lease obligation 0 4,694,000 0
Operating lease expense 31,141,000    
Impairment of non-marketable equity investment 0 5,110,000 1,890,000
Stock-based compensation expense 43,294,000 43,410,000 45,720,000
Other, net 178,000 254,000 755,000
Changes in assets and liabilities:      
Accounts receivable (35,395,000) (21,111,000) 25,849,000
Inventory (42,840,000) (8,617,000) 2,727,000
Prepaid expenses and other assets (93,621,000) (13,458,000) (8,194,000)
Accounts payable 83,272,000 (520,000) (4,763,000)
Accrued liabilities and other expenses 54,658,000 (21,490,000) (14,395,000)
Deferred revenue 25,658,000 7,994,000 16,416,000
Net cash used in operating activities (167,350,000) (99,083,000) (21,925,000)
Cash Flows from Investing Activities:      
Purchase of available-for-sale investments 0 (2,986,000) (160,215,000)
Proceeds from sales of available-for-sale investments 1,499,000 53,039,000 10,531,000
Proceeds from maturities of investments 25,085,000 102,112,000 152,876,000
Acquisition of business, net of cash acquired (10,000,000) (102,899,000) 0
Proceeds from sale of non-marketable equity investments 1,009,000 1,050,000 0
Purchase of property and equipment, net (30,202,000) (37,692,000) (58,041,000)
Net cash provided by (used in) investing activities (12,609,000) 12,624,000 (54,849,000)
Cash Flows from Financing Activities:      
Proceeds from issuance of 2024 Notes 0 391,431,000 0
Proceeds from mortgage payable 8,584,000 0 0
Proceeds from short-term borrowings 24,310,000 0 0
Proceeds from revolving line of credit 48,125,000 0 0
Purchase of capped call transactions 0 (48,880,000) 0
Repayment of revolving line of credit (20,000,000) 0 0
Repayment of mortgage payable (300,000) (150,000,000) 0
Payment of debt issuance cost (273,000) 0 0
Principal payments on financing lease obligations (163,000) (1,211,000) 0
Acquisition of non-controlling interest 0 0 (471,000)
Proceeds from issuance of common stock 12,053,000 17,693,000 17,991,000
Minimum tax withholding paid on behalf of employees for net share settlement (426,000) (1,144,000) (1,034,000)
Net cash provided by financing activities 71,910,000 207,889,000 16,486,000
Effect of exchange rate changes on cash (1,491,000) (579,000) 4,194,000
Net change in cash and cash equivalents (109,540,000) 120,851,000 (56,094,000)
Cash, cash equivalents and restricted cash at beginning of period 242,337,000 [1] 121,486,000 [1] 177,580,000
Cash, cash equivalents and restricted cash at end of period [1] 132,797,000 242,337,000 121,486,000
Supplemental disclosures of cash flow information:      
Cash paid for income taxes, net of refunds 16,944,000 6,692,000 5,690,000
Cash paid for interest 9,564,000 3,554,000 2,639,000
Supplemental schedule of non-cash investing and financing activities:      
Transfer of inventory to fixed assets 2,961,000 3,787,000 4,950,000
Common stock issued in connection with acquisition 0 129,628,000 0
Third-party manufacturer funding for transfer expenses incurred 6,960,000 0 0
Unpaid debt issuance cost $ 2,493 $ 0 $ 0
[1] Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets:
 
December 29, 2019
 
December 29, 2018
 
December 30, 2017
 
 
 
 
 
 
 
(In thousands)
Cash and cash equivalents
$
109,201

 
$
202,954

 
$
116,345

Short-term restricted cash
4,339

 
13,229

 
544

Long-term restricted cash
19,257

 
26,154

 
4,597

Total cash, cash equivalents and restricted cash
$
132,797

 
$
242,337

 
$
121,486